Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|October 10, 2015
Clinical implications of basic research in hepatocellular carcinomaRenumathy Dhanasekaran, Sudhakar K Venkatesh, Michael S Torbenson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 6, 2021
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United StatesAllison J Kwong, T Tara Ghaziani, Francis Yao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2012
Liver test results do not identify liver disease in adults with α(1)-antitrypsin deficiencyVirginia C Clark, Renumathy Dhanasekaran, Mark Brantly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrenceRenumathy Dhanasekaran, William Sanchez, Taofic Mounajjed, et al.
Journal for Immunotherapy of Cancer|November 22, 2018
Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinomaIan Lai, Srividya Swaminathan, Virginie Baylot, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 2, 2010
Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary studyRenumathy Dhanasekaran, David A Kooby, Charles A Staley, et al.
Clinical Transplantation|October 24, 2020
Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-transplant Clinical OutcomeNia Adeniji, Vinodhini Arjunan, Vijay Prabhakar, et al.
Journal of Surgical Oncology|March 10, 2010
Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)Renumathy Dhanasekaran, David A Kooby, Charles A Staley, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
A Novel Niclosamide Sulfate Prodrug with Enhanced Bioavailability Suppresses Hepatocellular Carcinoma via Inhibition of Multiple Signaling PathwaysMingdian Tan, Steve Schow, Yi Liu, et al.
Nature Reviews. Clinical Oncology|September 11, 2021
The MYC oncogene - the grand orchestrator of cancer growth and immune evasionRenumathy Dhanasekaran, Anja Deutzmann, Wadie D Mahauad-Fernandez, et al.
Pageof 8